Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about SUPN
Recent news which mentions SUPN
< Previous
1
2
Next >
Earnings Scheduled For August 5, 2025
August 05, 2025
Tickers
ACEL
ACHC
ACLS
ACRE
Tags
ALAB
ADM
TDC
From
Benzinga
These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News
June 17, 2025
Tickers
NEWS
SAGE
SUPN
Tags
Trading Ideas
News
PT Changes
From
Benzinga
Supernus Pharma Acquires Maker Of Postpartum Depression Drug Zurzuvae In $795 Million Deal
June 16, 2025
Tickers
BIIB
NEWS
SAGE
SUPN
Tags
News
why it's moving
Market News
From
Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
Tickers
ACA
ACLS
ADM
AEP
Tags
WLFC
LITE
CEG
From
Benzinga
Uncovering Potential: Supernus Pharmaceuticals's Earnings Preview
May 05, 2025
Tickers
SUPN
Tags
Earnings
BZI/EP
SUPN
From
Benzinga
Earnings Scheduled For February 25, 2025
February 25, 2025
Tickers
AGL
AHCO
AHT
ALC
Tags
ONTF
MRVI
PLNT
From
Benzinga
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
February 19, 2025
Tickers
CRVO
NEWS
QGEN
SUPN
Tags
Benzinga
Pre/Market Outlook
QGEN
From
Benzinga
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
February 19, 2025
Tickers
NEWS
SUPN
Tags
News
why it's moving
Market News
From
Benzinga
Gentherm Posts Downbeat Results, Joins Celanese, Bumble And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
February 19, 2025
Tickers
BMBL
CE
ETSY
GCL
Tags
Movers
Trading Ideas
THRM
From
Benzinga
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
February 19, 2025
Tickers
ADTX
APTO
BMBL
CE
Tags
LYT
MGOL
SINT
From
Benzinga
Screening For Black Friday Bargains In The Stock Market
December 03, 2024
Tickers
EXPE
NBIX
NVDA
SUPN
Tags
SUPN
TSLA
NVDA
From
Benzinga
ADHD Drug Maker Supernus Pharmaceuticals Downgraded On Slower Prescription Growth For Its Top-Selling Drug
September 11, 2024
Tickers
NEWS
SUPN
Tags
Stories That Matter
General
Analyst Ratings
From
Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
September 11, 2024
Tickers
ACET
ANIP
NEWS
NVS
Tags
Benzinga
Top Downgrades
SUPN
From
Benzinga
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
September 11, 2024
Tickers
APP
ASO
ATOS
CAC
Tags
Trading Ideas
APP
SUPN
From
Benzinga
If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names
July 19, 2024
Tickers
GILD
JAZZ
SUPN
Tags
SUPN
GILD
NASDAQ:GILD,NASDAQ:JAZZ,NASDAQ:SUPN
From
InvestorPlace
SUPN Stock Earnings: Supernus Pharmaceuticals Misses Revenue for Q1 2024
May 08, 2024
Tickers
SUPN
Tags
SUPN
Earnings Reports
Market News
From
InvestorPlace
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease
April 08, 2024
Tickers
NEWS
SUPN
Tags
why it's moving
Health Care
Market News
From
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 08, 2024
Tickers
ADIL
BRTX
GCTK
GTHX
Tags
Movers
GTHX
PETV
From
Benzinga
Recap: Supernus Pharmaceuticals Q4 Earnings
February 27, 2024
Tickers
SUPN
Tags
Earnings
SUPN
Market News
From
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Tickers
A
ACAD
ACHC
AEP
Tags
RVLV
FSS
BWXT
From
Benzinga
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
December 14, 2023
Tickers
BIIB
CYBN
SUPN
Tags
Market News
Stocks to Buy
NYSE:CYBN,NASDAQ:SUPN,NASDAQ:BIIB
From
InvestorPlace
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
Tickers
ABBV
EOLS
RVNC
SUPN
Tags
RVNC
SUPN
Briefs
From
Benzinga
Supernus Pharmaceuticals: Q3 Earnings Insights
November 08, 2023
Tickers
SUPN
Tags
Benzinga
BZI/Recaps
Market News
From
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.